<?xml version="1.0" encoding="UTF-8"?>
<p>The major cell surface receptor in the respiratory tract for both SARS‐CoV and SARS‐CoV‐2 is angiotensin converting enzyme 2.
 <xref rid="jmv26066-bib-0005" ref-type="ref">
  <sup>5</sup>
 </xref> Such receptors, however, are also plentiful in the gastrointestinal tract thus giving credibility to the potential for these viruses to attach and infect gastrointestinal epithelium.
 <xref rid="jmv26066-bib-0021" ref-type="ref">
  <sup>21</sup>
 </xref>, 
 <xref rid="jmv26066-bib-0150" ref-type="ref">
  <sup>150</sup>
 </xref>, 
 <xref rid="jmv26066-bib-0151" ref-type="ref">
  <sup>151</sup>
 </xref>, 
 <xref rid="jmv26066-bib-0152" ref-type="ref">
  <sup>152</sup>
 </xref> Growth in human small intestinal organoids has been successfully achieved with both wild‐type SARS‐CoV‐2 and a related chimeric virus.
 <xref rid="jmv26066-bib-0139" ref-type="ref">
  <sup>139</sup>
 </xref>, 
 <xref rid="jmv26066-bib-0141" ref-type="ref">
  <sup>141</sup>
 </xref>, 
 <xref rid="jmv26066-bib-0147" ref-type="ref">
  <sup>147</sup>
 </xref> One such study included growth in bat intestinal organoids.
 <xref rid="jmv26066-bib-0141" ref-type="ref">
  <sup>141</sup>
 </xref>
</p>
